Panel Discussion: The Reality of Cryo-EM Access, Bottlenecks & Future Directions
- Comparing access, cost, and timelines for large pharma versus biotechs, and when outsourcing or academic partnerships make more sense
- Addressing challenges around data volume, selection, and cloud storage
- How data processing, classification, and refinement workflows impact turnaround time and confidence in results
- Current constraints including size limits, flexibility, heterogeneity, and challenges with smaller molecules or weak interactions
- Emerging hardware, sample preparation strategies, and computational advances aimed at improving resolution, throughput, and applicability